2-benzyl-3-[[4-(3,4-dichlorophenyl)-5-(2,2,2-trifluoroethyl)-1,3-thiazol-2-yl]amino]propanoic acid
C21H17Cl2F3N2O2S — CID 156849055
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-benzyl-3-[[4-(3,4-dichlorophenyl)-5-(2,2,2-trifluoroethyl)-1,3-thiazol-2-yl]amino]propanoic acid
2-benzyl-3-[[4-(3,4-dichlorophenyl)-5-(2,2,2-trifluoroethyl)-1,3-thiazol-2-yl]amino]propanoic acid (PubChem CID 156849055) has the molecular formula C21H17Cl2F3N2O2S and a molecular weight of 489.35 g/mol. Its IUPAC name is 2-benzyl-3-[[4-(3,4-dichlorophenyl)-5-(2,2,2-trifluoroethyl)-1,3-thiazol-2-yl]amino]propanoic acid.
Molecular Properties
| Compound Name | 2-benzyl-3-[[4-(3,4-dichlorophenyl)-5-(2,2,2-trifluoroethyl)-1,3-thiazol-2-yl]amino]propanoic acid |
|---|---|
| PubChem CID | 156849055 |
| Molecular Formula | C21H17Cl2F3N2O2S |
| Molecular Weight | 489.35 g/mol |
| Exact Mass | 488.03 |
| IUPAC Name | 2-benzyl-3-[[4-(3,4-dichlorophenyl)-5-(2,2,2-trifluoroethyl)-1,3-thiazol-2-yl]amino]propanoic acid |
| SMILES | O=C(O)C(CNc1nc(-c2ccc(Cl)c(Cl)c2)c(CC(F)(F)F)s1)Cc1ccccc1 |
| InChI | InChI=1S/C21H17Cl2F3N2O2S/c22-15-7-6-13(9-16(15)23)18-17(10-21(24,25)26)31-20(28-18)27-11-14(19(29)30)8-12-4-2-1-3-5-12/h1-7,9,14H,8,10-11H2,(H,27,28)(H,29,30) |
| InChIKey | DZQBDFVVXMNYFP-UHFFFAOYSA-N |
| XLogP | 6.58 |
| TPSA | 62.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.35 |
| LogP ≤ 5 | 6.58 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156849055 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.